Quentin A. Hill

3.7k total citations · 1 hit paper
60 papers, 1.8k citations indexed

About

Quentin A. Hill is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Quentin A. Hill has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 21 papers in Genetics and 15 papers in Physiology. Recurrent topics in Quentin A. Hill's work include Blood groups and transfusion (35 papers), Platelet Disorders and Treatments (26 papers) and Erythrocyte Function and Pathophysiology (15 papers). Quentin A. Hill is often cited by papers focused on Blood groups and transfusion (35 papers), Platelet Disorders and Treatments (26 papers) and Erythrocyte Function and Pathophysiology (15 papers). Quentin A. Hill collaborates with scholars based in United Kingdom, United States and France. Quentin A. Hill's co-authors include Anita Hill, Sigbjørn Berentsen, Roger G. Owen, Drew Provan, John D. Grainger, Adrian C. Newland, Marc Michel, R. Stamps, Edwin Massey and Catherine M. Broome and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Quentin A. Hill

56 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting

2019 286 citations Ulrich Jäger, Wilma Barcellini et al. Blood Reviews profile →

Peers

Countries citing papers authored by Quentin A. Hill

Since Specialization

Citations

This map shows the geographic impact of Quentin A. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quentin A. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quentin A. Hill more than expected).

Fields of papers citing papers by Quentin A. Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quentin A. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quentin A. Hill. The network helps show where Quentin A. Hill may publish in the future.

Co-authorship network of co-authors of Quentin A. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Quentin A. Hill. A scholar is included among the top collaborators of Quentin A. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quentin A. Hill. Quentin A. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 3 Study to evaluate the efficacy and safety of rilzabrutinib in primary warm autoimmune hemolytic anemia (wAIHA): LUMINA 3 Study design 2025 ·Blood ·David J. Kuter, Quentin A. Hill, Bruno Fattizzo, Deepthi Jayawardene, Ahmed Daak	0
2	FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change 2025 ·SHILAP Revista de lepidopterología ·David Cella, Quentin A. Hill, (unknown), (unknown), (unknown), Frank Shafer, Marek Wardęcki, Mark Kosinski, Alexander Röth	1
3	Part a Efficacy and Safety of Oral Bruton Tyrosine Kinase Inhibitor (BTKi) Rilzabrutinib in Patients with Warm Autoimmune Hemolytic Anemia (wAIHA): Multicenter, Open-Label, Phase 2b Study 2024 ·Blood ·Nichola Cooper, David J. Kuter, Henrik Frederiksen, (unknown), (unknown), Wilma Barcellini, Joan Cid, Catherine M. Broome, (unknown), Amitabha Mazumder, Alessandro Lucchesi, Xin Zhao, Antonio M. Risitano, Sangeeta Sawhney, Quentin A. Hill, Deepthi Jayawardene, (unknown), J. Zhao, Ahmed Daak	6
4	Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension 2024 ·EClinicalMedicine ·Alexander Röth, Catherine M. Broome, Wilma Barcellini, Bernd Jilma, Quentin A. Hill, David Cella, Tor Henrik Anderson Tvedt, Masaki Yamaguchi, (unknown), Michelle Lee, Frank Shafer, Marek Wardęcki, Deepthi Jayawardene, (unknown), Jérôme Msihid, Ilene C. Weitz	1
5	Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD‐SIQ) 2023 ·European Journal Of Haematology ·(unknown), Pronabesh DasMahapatra, Dana DiBenedetti, Katherine Kosa, Quentin A. Hill	1
6	Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy 2022 ·Blood ·Andrew J. Doyle, Matthew Stubbs, Tina Dutt, Will Lester, Will Thomas, (unknown), (unknown), Tanya Cranfield, Quentin A. Hill, Amanda Clark, Catherine Bagot, Steve Austin, John‐Paul Westwood, Mari Thomas, Marie Scully	10
7	Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia 2021 ·Advances in Therapy ·(unknown), (unknown), Laura Grant, Nichola Cooper, Donald M. Arnold, (unknown), Drew Provan, Adam Cuker, Quentin A. Hill, Yoshiaki Tomiyama, Waleed Ghanima	6
8	Clinically Important Change in SF-12v2 Physical (PCS) and Mental (MCS) Component Summary Scores for Patients with Cold Agglutinin Disease: An Analysis Using the Phase 3 CARDINAL and CADENZA Studies 2021 ·Blood ·(unknown), Mark Kosinski, Frank Shafer, Marek Wardęcki, (unknown), Quentin A. Hill	5
9	Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel 2021 ·Acta Haematologica ·Nichola Cooper, Quentin A. Hill, John D. Grainger, John‐Paul Westwood, Charlotte Bradbury, Drew Provan, Jecko Thachil, (unknown), Anuja Roy	19
10	Outcome of national oversight of intravenous immunoglobulin prescribing in immune thrombocytopenia 2020 ·Journal of Clinical Pathology ·Siraj Misbah, Michael Murphy, Sue Pavord, Quentin A. Hill, (unknown), (unknown), Mark Foster	1
11	Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia 2020 ·British Journal of Haematology ·Ralph V. Boccia, Nichola Cooper, Waleed Ghanima, Michael Boxer, Quentin A. Hill, Michelle Sholzberg, Michael D. Tarantino, Leslie Todd, Sandra Tong, James B. Bussel	46
12	Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting breakdown → 2019 ·Blood Reviews ·Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, Morie A. Gertz, Anita Hill, Quentin A. Hill, Bernd Jilma, David J. Kuter, Marc Michel, Marco Montillo, Alexander Röth, Sacha Zeerleder, Sigbjørn Berentsen	286
13	Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial 2018 ·BMJ Open ·(unknown), Rosemary Greenwood, Jenny Ingram, (unknown), Ian Thomas, Rebecca Kandiyali, Andrew Mumford, Andrew D. Dick, Catherine Bagot, Nichola Cooper, Quentin A. Hill, Charlotte Bradbury	16
14	Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data 2018 ·Critical Care ·(unknown), Élie Azoulay, Djamel Mokart, Márcio Soares, Kyeongman Jeon, Sandra Oeyen, Chin Kook Rhee, Pascale Gruber, Marlies Ostermann, Quentin A. Hill, Pieter Depuydt, Christelle Ferrá, Anne‐Claire Toffart, Peter Schellongowski, Alice Mânica Müller, Virginie Lemiale, Fabien Tinquaut, Aurélie Bourmaud, Michaël Darmon	40
15	Immune thrombocytopenia: improving quality of life and patient outcomes 2018 ·SHILAP Revista de lepidopterología ·Patrick Trotter, Quentin A. Hill	39
16	Autoimmune haemolytic anaemia 2016 ·ISBT Science Series ·S. Allard, Quentin A. Hill	6
17	Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study 2011 ·Leukemia & lymphoma ·Quentin A. Hill, Richard Kelly, (unknown), (unknown), Andy Scally, Anthony Hughes, A. John Ashcroft, Anita Hill	24
18	Towards better blood transfusion – recruitment and training 2009 ·Transfusion Medicine ·Quentin A. Hill, Anita Hill, S. Allard, Michael Murphy	7
19	Intensify, resuscitate or palliate: Decision making in the critically ill patient with haematological malignancy 2009 ·Blood Reviews ·Quentin A. Hill	45
20	CNS prophylaxis in lymphoma: Who to target and what therapy to use 2006 ·Blood Reviews ·Quentin A. Hill, Roger G. Owen	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact